Tanilive 100 & 200 Mg Vaginal Capsules 100 or 200 mg Soft gelatin capsule.
PDF Leaflet Revision Date: 03 July 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Progesterone support in ovarian insufficiency, IVF cycles, and threatened miscarriage.
Dosage (summary)
100 mg daily on days 13-14, 200 mg on days 15-25; max 600 mg/day if pregnancy occurs.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Use restricted to first trimester; contraindicated in breastfeeding.
Key Drug Interactions
- Enzyme inducers (e.g., carbamazepine)
- Enzyme inhibitors (e.g., ketoconazole)
- Anticoagulants
Contraindications
- Hypersensitivity to progesterone
- Severe liver disease
- Undiagnosed vaginal bleeding
- Thromboembolic disorders
Common side effects
- Drowsiness
- Dizziness
- Vaginal discharge
Counselling Points
- Insert capsule deep into the vagina
- Monitor for mood changes
- Avoid driving until effects are known
Serious warnings
- Risk of thromboembolism
- Breast cancer risk
- Endometrial hyperplasia risk
Important Disclaimer
The Tanilive 100 & 200 Mg Vaginal Capsules 100 or 200 mg Soft gelatin capsule. professional information leaflet below is the property of Pharma Dynamics and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
